- Home
- PSFE vs ARCT Comparison
PSFE vs ARCT Comparison
Compare PSFE & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSFE | ARCT |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.3M | 293.9M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PSFE | ARCT |
|---|---|---|
| Price | $5.94 | $9.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $8.50 | ★ $23.80 |
| AVG Volume (30 Days) | 305.6K | ★ 631.2K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | $6.51 | N/A |
| Revenue Next Year | $5.37 | $64.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.29 | $5.50 |
| 52 Week High | $10.81 | $17.96 |
Technical Indicators
Market Signals| Indicator | PSFE | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 38.22 |
| Support Level | $5.35 | $6.53 |
| Resistance Level | $6.83 | $17.85 |
| Average True Range (ATR) | 0.28 | 0.99 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 80.00 | 1.77 |
Price Performance
Historical ComparisonAbout PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company's reportable segments are Merchant Solutions and Digital Wallets. The Merchant Solutions segment, which derives maximum revenue, services markets in North America, Canada and Europe. The Digital Wallets segment services markets in Europe, UK, North America and Latin America. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.